
Overview
Aaron P. Provenzano, DO, is a hematologist/medical oncologist and treats all types of cancers using chemotherapy, immunotherapy, and molecularly targeted therapies. He also evaluates and manages blood disorders, both benign and malignant.
Dr. Provenzano is highly rated in 37 conditions, according to our data. His top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Cancer, Pleuropulmonary Blastoma, and Hemophilia B.
His clinical research consists of co-authoring 1 peer reviewed article and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.
Graduate Institution
Residency
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE-MEDICAID PLAN
- HMO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- MANAGED MEDICAID PLAN
- HMO
- MANAGED MEDICAID PLAN
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
3204 Johnson Road, Steubenville, OH 43952
Additional Areas of Focus
Dr. Provenzano has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
7 Clinical Trials
UPMC Hillman Cancer Center
Melissa Burgess, MD, is an assistant professor at the University of Pittsburgh School of Medicine and a medical oncologist. She specializes in the treatment of soft tissue and bone sarcomas and Merkel cell carcinoma. Dr. Burgess is highly rated in 42 conditions, according to our data. Her top areas of expertise are Adult Soft Tissue Sarcoma, Liposarcoma, Merkel Cell Carcinoma, Chondrosarcoma, and Gamma Knife Radiosurgery.
UPMC Hillman Cancer Center
Dan P. Zandberg, MD, is an associate professor of medicine and a medical oncologist/hematologist, specializing in the treatment of head and neck and thyroid cancers. He is the Director of the Head and Neck and Thyroid Cancer disease sections for the division of Hematology/Oncology and the Medical Oncology Co-Leader of the UPMC Hillman Head and Neck Cancer Program. He is also the physician lead for the second floor Hillman Cancer Center clinic. His main research focus is in the development of clinical trials with immunotherapy to improve patient outcomes. Recent awards include the 2019 National Cancer Institute (NCI) Cancer Clinical Investigator Team Leadership Award, 2020 Leo Criep, M.D. Excellence in Patient Care Award, and 2020/2021 Castle Connolly Regional Top Doctor. Dr. Zandberg is highly rated in 23 conditions, according to our data. His top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Oral Squamous Cell Carcinoma, Small Cell Lung Cancer (SCLC), and ALK-Positive Non-Small Cell Lung Cancer.
UPMC Hillman Cancer Center
Adam M. Brufsky, MD, PhD, FACP, is professor of medicine at the University of Pittsburgh School of Medicine and also serves as the associate division chief for the Division of Hematology/Oncology at the University of Pittsburgh School of Medicine's Department of Medicine. Dr. Brufsky is the medical director of the Magee-Women's Cancer Program, part of the UPMC Hillman Cancer Center, and UPMC Hillman Cancer Center; associate director for clinical investigations at UPMC Hillman Cancer Center; and codirector of the Comprehensive Breast Cancer Center.Dr. Brufsky is board-certified in internal medicine and medical oncology. He earned a medical and doctor of philosophy degrees from the University of Connecticut School of Medicine in Farmington, Conn.; completed a residency at Brigham and Women's Hospital, Harvard Medical School, and a fellowship at Dana-Farber Cancer Institute.Dr. Brufsky is a member of professional organizations, such as American Medical Association, Massachusetts Medical Society, American College of Physicians, American Society of Clinical Oncology, American Association for Cancer Research, Allegheny County Medical Society, Pennsylvania Medical Society, and Pennsylvania Oncologic Society. An active researcher, Dr. Brufsky has numerous abstracts and research articles in leading journals, and is principal investigator on a number of research grants funded by the National Institutes of Health, Susan G. Komen Foundation, and US Army - Breast Cancer Research Program. Dr. Brufsky is highly rated in 14 conditions, according to our data. His top areas of expertise are Breast Cancer, Triple-Negative Breast Cancer, Inflammatory Breast Cancer, Breast Cancer in Men, and Gastrostomy.
Frequently Asked Questions about Dr. Aaron P. Provenzano
How do I make an appointment with Dr. Aaron P. Provenzano?
You can book an appointment with Dr. Aaron P. Provenzano by calling their office at 740-266-3900. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Aaron P. Provenzano a top-rated expert for Small Cell Lung Cancer (SCLC)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Aaron P. Provenzano is classified as an Distinguished expert for Small Cell Lung Cancer (SCLC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Aaron P. Provenzano specialize in?
While Dr. Aaron P. Provenzano is a Hematology Oncology, they have specific expertise in Small Cell Lung Cancer (SCLC), Lung Cancer, and Pleuropulmonary Blastoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology Oncology.
Does Dr. Aaron P. Provenzano participate in research or clinical trials?
Yes. Dr. Aaron P. Provenzano has published 1 articles and abstracts on conditions like Small Cell Lung Cancer (SCLC). You can view a list of Dr. Aaron P. Provenzano's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Aaron P. Provenzano accept my insurance?
Dr. Aaron P. Provenzano accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 740-266-3900 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- AstrocytomaDr. Provenzano isDistinguished. Learn about Astrocytoma.
- Atypical Teratoid Rhabdoid Tumor (ATRT)Dr. Provenzano isDistinguished. Learn about Atypical Teratoid Rhabdoid Tumor (ATRT).
- Embryonal Tumor with Multilayered RosettesDr. Provenzano isDistinguished. Learn about Embryonal Tumor with Multilayered Rosettes.
- GliosarcomaDr. Provenzano isDistinguished. Learn about Gliosarcoma.
- Hemophilia BDr. Provenzano isDistinguished. Learn about Hemophilia B.
- Lung CancerDr. Provenzano isDistinguished. Learn about Lung Cancer.
- Advanced
- ALK-Positive Non-Small Cell Lung CancerDr. Provenzano isAdvanced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Brain TumorDr. Provenzano isAdvanced. Learn about Brain Tumor.
- Breast CancerDr. Provenzano isAdvanced. Learn about Breast Cancer.
- Childhood Iron Deficiency AnemiaDr. Provenzano isAdvanced. Learn about Childhood Iron Deficiency Anemia.
- Colorectal CancerDr. Provenzano isAdvanced. Learn about Colorectal Cancer.
- EGFR Positive Lung CancerDr. Provenzano isAdvanced. Learn about EGFR Positive Lung Cancer.
- Experienced
- Acinic Cell Carcinoma of Salivary GlandsDr. Provenzano isExperienced. Learn about Acinic Cell Carcinoma of Salivary Glands.
- Acute Eosinophilic PneumoniaDr. Provenzano isExperienced. Learn about Acute Eosinophilic Pneumonia.
- Acute Mountain SicknessDr. Provenzano isExperienced. Learn about Acute Mountain Sickness.
- Acute Promyelocytic LeukemiaDr. Provenzano isExperienced. Learn about Acute Promyelocytic Leukemia.
- Adenoid Cystic CarcinomaDr. Provenzano isExperienced. Learn about Adenoid Cystic Carcinoma.
- Adult Soft Tissue SarcomaDr. Provenzano isExperienced. Learn about Adult Soft Tissue Sarcoma.



